Additionally, they present promising potential therapeutic opportunities in cancer treatment, including in response to chemoresistance and subsequent BCa recurrence, targeting the TGFβ1/lncRNA-LET/miR-145 axis (11). The gene discussed is TGFB1; the disease is cancer.